Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Roger Guillemin

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Anatomy

Living Beings

Rats
Sheep

Chemicals & Drugs

Genes & Molecular Sequences

Amino Acid Sequence

Procedures

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
28
Baird, Andrew
15
Schally, Andrew
4
Yen, Samuel
2
Naftolin, Frederick
2
Shimasaki, Shunichi
2
Bone, Henry
1
Brown, Herbert
1
Curl, Robert
1
Dulbecco, R
1
Fleischer, Norman
1
Greengard, Paul
1
Hauptman, Herbert
1
Heeger, Alan
1
Herschbach, Dudley
1
Hubel, David

Sign-in to see all Coauthors

Publications

TOP 3
Guillemin Roger
Somatostatin: the beginnings, 1972.
Guillemin R; Perrin M H
Neuroendocrinology: past, present and future.
Guillemin R
Basic research and the practice of medicine.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Roger Guillemin (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Guillemin Roger
Somatostatin: the beginnings, 1972.
Molecular and cellular endocrinology 2008;286(1-2):3-4.
2008: Guillemin R; Perrin M H
Neuroendocrinology: past, present and future.
Annales d'endocrinologie 2008;69(2):160.
2006: Guillemin R
Basic research and the practice of medicine.
Annales de cardiologie et d'angéiologie 2006;55(2):63.
2006: Guillemin Roger
Acromegaly, day one and now, 120 years later.
Neuroendocrinology 2006;83(3-4):136-8.
2005: Guillemin Roger
Hypothalamic hormones a.k.a. hypothalamic releasing factors.
The Journal of endocrinology 2005;184(1):11-28.
2004: Guillemin Roger
Neuroendocrine basis of human disease.
Annals of the New York Academy of Sciences 2004;1038():131-7.
2001: Arrow K J; Axelrod J; Benacerraf B; Berg P; Bishop J M; Bloembergen N; Brown H C; Cibelli J; Cohen S; Cooper L N; Corey E J; Cronin J W; Curl R; Dulbecco R; Fischer E H; Fitch V L; Fogel R; Friedman J I; Furchgott R F; Gell-Mann M; Gilbert W; Gilman A; Glaser D; Glashow S L; Green R M; Greengard P; Guillemin R; Hayflick L; Hauptman H A; Heckman J J; Heeger A; Herschbach D; Hubel D H; Hulse R; Kandel E; Karle J; Klein L R; Kohn W; Kornberg A; Krebs E G; Lanza R P; Laughlin R; Lederman L; Lee D M; Lewis E; Lipscomb W; Marcus R A; McFadden D; Merrifield R B; Merton R; Modigliani F; Molina M J; Murad F; Nirenberg M W; North D C; Olah G A; Osheroff D; Palade G E; Perl M; Ramsey N F; Richter B; Roberts R J; Samuelson P A; Schwartz M; Sharp P A; Smalley R E; Smith H O; Solow R M; Stormer H; Taube H; Taylor R; Thomas E D; Tobin J; Tonegawa S; Townes C; Watson J D; Weinberg S; Weller T H; West M D; Wieschaus E F; Wiesel T N; Wilson R W
Nobel laureates' letter to President Bush.
Washington post (Washington, D.C. : 1974) 2001;():A02.
1995: Lerner R A; Guillemin R
Floyd Bloom: the next editor-in-chief of Science.
Science (New York, N.Y.) 1995;267(5203):1441-2.
1993: Guillemin R
Somatostatin: the early days.
Digestion 1993;54 Suppl 1():3-6.
1992: Guillemin R
Somatostatin: the early days.
Metabolism: clinical and experimental 1992;41(9 Suppl 2):2-4.
1988: Cheifetz S; Ling N; Guillemin R; Massagué J
A surface component on GH3 pituitary cells that recognizes transforming growth factor-beta, activin, and inhibin.
The Journal of biological chemistry 1988;263(33):17225-8.
1988: Leppäluoto J; Zeytin F; Ueno N; Ying S Y; Ling N; Guillemin R
Myelin basic protein present in the acid extracts of rat hypothalami releases insulin and glucagon from isolated rat pancreatic islets.
Acta physiologica Scandinavica 1988;134(2):253-61.
1988: Shimasaki S; Koga M; Esch F; Cooksey K; Mercado M; Koba A; Ueno N; Ying S Y; Ling N; Guillemin R
Primary structure of the human follistatin precursor and its genomic organization.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(12):4218-22.
1988: Baird A; Schubert D; Ling N; Guillemin R
Receptor- and heparin-binding domains of basic fibroblast growth factor.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(7):2324-8.
1988: Ying S Y; Ling N; Guillemin R
Inhibins and activins. Structures and radioimmunoassays.
Annals of the New York Academy of Sciences 1988;541():143-52.
1988: Ling N; Ueno N; Ying S Y; Esch F; Shimasaki S; Hotta M; Cuevas P; Guillemin R
Inhibins and activins.
Vitamins and hormones 1988;44():1-46.
1987: Ueno N; Ling N; Ying S Y; Esch F; Shimasaki S; Guillemin R
Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(23):8282-6.
1987: Esch F S; Shimasaki S; Mercado M; Cooksey K; Ling N; Ying S; Ueno N; Guillemin R
Structural characterization of follistatin: a novel follicle-stimulating hormone release-inhibiting polypeptide from the gonad.
Molecular endocrinology (Baltimore, Md.) 1987;1(11):849-55.
1987: Ying S Y; Becker A; Swanson G; Tan P; Ling N; Esch F; Ueno N; Shimasaki S; Guillemin R
Follistatin specifically inhibits pituitary follicle stimulating hormone release in vitro.
Biochemical and biophysical research communications 1987;149(1):133-9.
1987: Ying S Y; Czvik J; Becker A; Ling N; Ueno N; Guillemin R
Secretion of follicle-stimulating hormone and production of inhibin are reciprocally related.
Proceedings of the National Academy of Sciences of the United States of America 1987;84(13):4631-5.
1987: Ueno N; Baird A; Esch F; Ling N; Guillemin R
Isolation and partial characterization of basic fibroblast growth factor from bovine testis.
Molecular and cellular endocrinology 1987;49(2-3):189-94.
1987: Cuevas P; Ying S Y; Ling N; Ueno N; Esch F; Guillemin R; Healy D; Ta S
Immunohistochemical detection of inhibin in the gonad.
Biochemical and biophysical research communications 1987;142(1):23-30.
1986: Ueno N; Baird A; Esch F; Shimasaki S; Ling N; Guillemin R
Purification and partial characterization of a mitogenic factor from bovine liver: structural homology with basic fibroblast growth factor.
Regulatory peptides 1986;16(2):135-45.
1986: Montesano R; Vassalli J D; Baird A; Guillemin R; Orci L
Basic fibroblast growth factor induces angiogenesis in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(19):7297-301.
1986: Ling N; Ying S Y; Ueno N; Shimasaki S; Esch F; Hotta M; Guillemin R
A homodimer of the beta-subunits of inhibin A stimulates the secretion of pituitary follicle stimulating hormone.
Biochemical and biophysical research communications 1986;138(3):1129-37.
1986: Ueno N; Baird A; Esch F; Ling N; Guillemin R
Isolation of an amino terminal extended form of basic fibroblast growth factor.
Biochemical and biophysical research communications 1986;138(2):580-8.
1986: Ling N; Ying S Y; Ueno N; Shimasaki S; Esch F; Hotta M; Guillemin R
Pituitary FSH is released by a heterodimer of the beta-subunits from the two forms of inhibin.
Nature 1986;321(6072):779-82.
1986: Walicke P; Cowan W M; Ueno N; Baird A; Guillemin R
Fibroblast growth factor promotes survival of dissociated hippocampal neurons and enhances neurite extension.
Proceedings of the National Academy of Sciences of the United States of America 1986;83(9):3012-6.
1986: Ying S Y; Becker A; Ling N; Ueno N; Guillemin R
Inhibin and beta type transforming growth factor (TGF beta) have opposite modulating effects on the follicle stimulating hormone (FSH)-induced aromatase activity of cultured rat granulosa cells.
Biochemical and biophysical research communications 1986;136(3):969-75.
1986: Ying S Y; Becker A; Baird A; Ling N; Ueno N; Esch F; Guillemin R
Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system.
Biochemical and biophysical research communications 1986;135(3):950-6.
1986: Ling N; Guillemin R
hpGRF-44-NH2, lot no. 92-81-5G-41-47, is (human) growth hormone-releasing factor containing no trace of (ovine) corticotropin-releasing factor.
Endocrinology 1986;118(3):1249-51.
1986: Matsuki A; Kudo T; Ishihara H; Jin T; Taneichi T; Oyama T; Guillemin R; Ling N
Plasma beta-endorphin levels during obstetrical analgesia with synthetic beta-endorphin.
Agressologie: revue internationale de physio-biologie et de pharmacologie appliquées aux effets de l'agression 1986;27(2):133-7.
1986: Bloch B; Baird A; Ling N; Guillemin R
Immunohistochemical evidence that growth hormone-releasing factor (GRF) neurons contain an amidated peptide derived from cleavage of the carboxyl-terminal end of the GRF precursor.
Endocrinology 1986;118(1):156-62.
1986: Baird A; Esch F; Mormède P; Ueno N; Ling N; Böhlen P; Ying S Y; Wehrenberg W B; Guillemin R
Molecular characterization of fibroblast growth factor: distribution and biological activities in various tissues.
Recent progress in hormone research 1986;42():143-205.
1986: Sassolas G; Guillemin R
[Current status of somatocrinin, or GRF, a hypothalamic growth hormone-secreting factor]
Annales d'endocrinologie 1986;47(5):332-41.
1985: Esch F; Ueno N; Baird A; Hill F; Denoroy L; Ling N; Gospodarowicz D; Guillemin R
Primary structure of bovine brain acidic fibroblast growth factor (FGF).
Biochemical and biophysical research communications 1985;133(2):554-62.
1985: Baird A; Esch F; Gospodarowicz D; Guillemin R
Retina- and eye-derived endothelial cell growth factors: partial molecular characterization and identity with acidic and basic fibroblast growth factors.
Biochemistry 1985;24(27):7855-60.
1985: Mason A J; Hayflick J S; Ling N; Esch F; Ueno N; Ying S Y; Guillemin R; Niall H; Seeburg P H
Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta.
Nature 1985;318(6047):659-63.
1985: Ling N; Ying S Y; Ueno N; Esch F; Denoroy L; Guillemin R
Isolation and partial characterization of a Mr 32,000 protein with inhibin activity from porcine follicular fluid.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(21):7217-21.
1985: Guillemin R
Walter B. Cannon memorial lecture. The language of polypeptides and the wisdom of the body.
The Physiologist 1985;28(5):391-6.
1985: Esch F; Baird A; Ling N; Ueno N; Hill F; Denoroy L; Klepper R; Gospodarowicz D; Böhlen P; Guillemin R
Primary structure of bovine pituitary basic fibroblast growth factor (FGF) and comparison with the amino-terminal sequence of bovine brain acidic FGF.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(19):6507-11.
1985: Baird A; Culler F; Jones K L; Guillemin R
Angiogenic factor in human ocular fluid.
Lancet 1985;2(8454):563.
1985: Baird A; Mormède P; Ying S Y; Wehrenberg W B; Ueno N; Ling N; Guillemin R
A nonmitogenic pituitary function of fibroblast growth factor: regulation of thyrotropin and prolactin secretion.
Proceedings of the National Academy of Sciences of the United States of America 1985;82(16):5545-9.
1985: Guillemin R
A personal reminiscence of Hans Selye.
Experientia 1985;41(5):560-1.
1985: Baird A; Böhlen P; Ling N; Guillemin R
Radioimmunoassay for fibroblast growth factor (FGF): release by the bovine anterior pituitary in vitro.
Regulatory peptides 1985;10(4):309-17.
1985: Ling N; Zeytin F; Böhlen P; Esch F; Brazeau P; Wehrenberg W B; Baird A; Guillemin R
Growth hormone releasing factors.
Annual review of biochemistry 1985;54():403-23.
1985: Benoit R; Bohlen P; Ling N; Esch F; Baird A; Ying S Y; Wehrenberg W B; Guillemin R; Morrison J H; Bakhit C
Somatostatin-28 [1-12]-like peptides.
Advances in experimental medicine and biology 1985;188():89-107.
1985: Wehrenberg W B; Baird A; Zeytin F; Esch F; Böhlen P; Ling N; Ying S Y; Guillemin R
Physiological studies with somatocrinin, a growth hormone-releasing factor.
Annual review of pharmacology and toxicology 1985;25():463-83.
1984: Böhlen P; Wehrenberg W B; Esch F; Ling N; Brazeau P; Guillemin R
Rat hypothalamic growth hormone-releasing factor: isolation, sequence analysis and total synthesis.
Biochemical and biophysical research communications 1984;125(3):1005-12.
1984: Brazeau P; Böhlen P; Esch F; Ling N; Wehrenberg W B; Guillemin R
Growth hormone-releasing factor from ovine and caprine hypothalamus: isolation, sequence analysis and total synthesis.
Biochemical and biophysical research communications 1984;125(2):606-14.
1984: Esch F; Ling N; Bohlen P; Baird A; Benoit R; Guillemin R
Isolation and characterization of the bovine hypothalamic corticotropin-releasing factor.
Biochemical and biophysical research communications 1984;122(3):899-905.
1984: Ling N; Esch F; Böhlen P; Baird A; Guillemin R
Isolation and characterization of caprine corticotropin-releasing factor.
Biochemical and biophysical research communications 1984;122(3):1218-24.
1984: Ling N; Esch F; Böhlen P; Brazeau P; Wehrenberg W B; Guillemin R
Isolation, primary structure, and synthesis of human hypothalamic somatocrinin: growth hormone-releasing factor.
Proceedings of the National Academy of Sciences of the United States of America 1984;81(14):4302-6.
1984: Wehrenberg W B; Baird A; Ying S Y; Rivier C; Ling N; Guillemin R
Multiple stimulation of the adenohypophysis by combinations of hypothalamic releasing factors.
Endocrinology 1984;114(6):1995-2001.
1984: Wehrenberg W B; Brazeau P; Ling N; Textor G; Guillemin R
Pituitary growth hormone response in rats during a 24-hour infusion of growth hormone-releasing factor.
Endocrinology 1984;114(5):1613-6.
1984: Guillemin R; Zeytin F; Ling N; Böhlen P; Esch F; Brazeau P; Bloch B; Wehrenberg W B
Growth hormone-releasing factor: chemistry and physiology.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1984;175(4):407-13.
1984: Hatron P Y; Wemeau J L; Guillemin R; Raviart B; Vanhille P; Devulder B
[Thyroid function in the nephrotic syndrome]
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1984;5(1):35-42.
1984: Bloch B; Ling N; Benoit R; Wehrenberg W B; Guillemin R
Specific depletion of immunoreactive growth hormone-releasing factor by monosodium glutamate in rat median eminence.
Nature 1984;307(5948):272-3.
1984: Wehrenberg W B; Bloch B; Chong-Li Z; Brazeau P; Ling N; Guillemin R
Pituitary response to growth hormone-releasing factor in rats with functional or anatomical lesions of the central nervous system that inhibit endogenous growth hormone secretion.
Regulatory peptides 1984;8(1):1-8.
1984: Guillemin R; Brazeau P; Böhlen P; Esch F; Ling N; Wehrenberg W B; Bloch B; Mougin C; Zeytin F; Baird A
Somatocrinin, the growth hormone releasing factor.
Recent progress in hormone research 1984;40():233-99.
1984: Mougin C; Brazeau P; Ling N; Lewin M; Guillemin R
[Roles of cyclic AMP and calcium in the mechanism of the release of growth hormone by somatocrinin]
Comptes rendus de l'Académie des sciences. Série III, Sciences de la vie 1984;299(4):83-8.
1983: Esch F; Böhlen P; Ling N; Brazeau P; Guillemin R
Isolation and characterization of the bovine hypothalamic growth hormone releasing factor.
Biochemical and biophysical research communications 1983;117(3):772-9.
1983: Böhlen P; Esch F; Brazeau P; Ling N; Guillemin R
Isolation and characterization of the porcine hypothalamic growth hormone releasing factor.
Biochemical and biophysical research communications 1983;116(2):726-34.
1983: Rosenthal S M; Schriock E A; Kaplan S L; Guillemin R; Grumbach M M
Synthetic human pancreas growth hormone-releasing factor (hpGRF1-44-NH2) stimulates growth hormone secretion in normal men.
The Journal of clinical endocrinology and metabolism 1983;57(3):677-9.
1983: Böhlen P; Brazeau P; Bloch B; Ling N; Gaillard R; Guillemin R
Human hypothalamic growth hormone releasing factor (GRF): evidence for two forms identical to tumor derived GRF-44-NH2 and GRF-40.
Biochemical and biophysical research communications 1983;114(3):930-6.
1983: Böhlen P; Brazeau P; Esch F; Ling N; Wehrenberg W B; Guillemin R
Human growth hormone releasing factor and somatostatin from two pancreatic tumors: isolation and characterization.
Regulatory peptides 1983;6(4):343-53.
1983: Esch F S; Ling N C; Böhlen P; Ying S Y; Guillemin R
Primary structure of PDC-109, a major protein constituent of bovine seminal plasma.
Biochemical and biophysical research communications 1983;113(3):861-7.
1983: Wehrenberg W B; Brazeau P; Luben R; Ling N; Guillemin R
A noninvasive functional lesion of the hypothalamo-pituitary axis for the study of growth hormone-releasing factor.
Neuroendocrinology 1983;36(6):489-91.
1983: Wehrenberg W B; Benoit R; Baird A; Guillemin R
Inhibitory effects of cysteamine on neuroendocrine function.
Regulatory peptides 1983;6(2):137-45.
1983: Guillemin R
A personal reminiscence of Hans Selye.
Laboratory investigation; a journal of technical methods and pathology 1983;48(4):367-8.
1983: Bloch B; Baird A; Ling N; Benoit R; Guillemin R
Immunohistochemical evidence that brain enkephalins arise from a precursor similar to adrenal preproenkephalin.
Brain research 1983;263(2):251-7.
1983: Bloch B; Brazeau P; Ling N; Bohlen P; Esch F; Wehrenberg W B; Benoit R; Bloom F; Guillemin R
Immunohistochemical detection of growth hormone-releasing factor in brain.
Nature 1983;301(5901):607-8.
1983: Esch F S; Böhlen P; Ling N C; Brazeau P E; Wehrenberg W B; Guillemin R
Primary structures of three human pancreas peptides with growth hormone-releasing activity.
The Journal of biological chemistry 1983;258(3):1806-12.
1983: Ravazzola M; Benoit R; Ling N; Guillemin R; Orci L
Immunocytochemical localization of prosomatostatin fragments in maturing and mature secretory granules of pancreatic and gastrointestinal D cells.
Proceedings of the National Academy of Sciences of the United States of America 1983;80(1):215-8.
1983: Sassolas G; Chayvialle J A; Partensky C; Berger G; Trouillas J; Berger F; Claustrat B; Cohen R; Girod C; Guillemin R
[Acromegaly, clinical expression of the production of growth hormone releasing factor in pancreatic tumors]
Annales d'endocrinologie 1983;44(6):347-54.
1982: Benoit R; Ling N; Bakhit C; Morrison J H; Alford B; Guillemin R
Somatostatin-28(1-12)-like immunoreactivity in the rat.
Endocrinology 1982;111(6):2149-51.
1982: Brazeau P; Ling N; Böhlen P; Esch F; Ying S Y; Guillemin R
Growth hormone releasing factor, somatocrinin, releases pituitary growth hormone in vitro.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(24):7909-13.
1982: Wehrenberg W B; Brazeau P; Luben R; Böhlen P; Guillemin R
Inhibition of the pulsatile secretion of growth hormone by monoclonal antibodies to the hypothalamic growth hormone releasing factor (GRF).
Endocrinology 1982;111(6):2147-8.
1982: Esch F S; Böhlen P; Ling N C; Brazeau P E; Wehrenberg W B; Thorner M O; Cronin M J; Guillemin R
Characterization of a 40 residue peptide from a human pancreatic tumor with growth hormone releasing activity.
Biochemical and biophysical research communications 1982;109(1):152-8.
1982: Brazeau P; Guillemin R; Ling N; van Wyk J; Humbel R
[Somatomedin inhibition of the growth hormone secretion stimulated by the hypothalamic factor somatocrinin or the synthetic peptide hpGRF]
Comptes rendus des séances de l'Académie des sciences. Série III, Sciences de la vie 1982;295(11):651-4.
1982: Wehrenberg W B; Ling N; Brazeau P; Esch F; Böhlen P; Baird A; Ying S; Guillemin R
Somatocrinin, growth hormone releasing factor, stimulates secretion of growth hormone in anesthetized rats.
Biochemical and biophysical research communications 1982;109(2):382-7.
1982: Luben R A; Brazeau P; Böhlen P; Guillemin R
Monoclonal antibodies to hypothalamic growth hormone-releasing factor with picomoles of antigen.
Science (New York, N.Y.) 1982;218(4575):887-9.
1982: Guillemin R; Brazeau P; Böhlen P; Esch F; Ling N; Wehrenberg W B
Growth hormone-releasing factor from a human pancreatic tumor that caused acromegaly.
Science (New York, N.Y.) 1982;218(4572):585-7.
1982: Brazeau P; Ling N; Esch F; Böhlen P; Mougin C; Guillemin R
Somatocrinin (growth hormone releasing factor) in vitro bioactivity; Ca++ involvement, cAMP mediated action and additivity of effect with PGE2.
Biochemical and biophysical research communications 1982;109(2):588-94.
1982: Wehrenberg W B; Ling N; Böhlen P; Esch F; Brazeau P; Guillemin R
Physiological roles of somatocrinin and somatostatin in the regulation of growth hormone secretion.
Biochemical and biophysical research communications 1982;109(2):562-7.
1982: Guillemin R
The brain as an endocrine organ--update 1981.
Endocrinologia experimentalis 1982;16(3-4):151-62.
1982: Benoit R; Ling N; Alford B; Guillemin R
Seven peptides derived from pro-somatostatin in rat brain.
Biochemical and biophysical research communications 1982;107(3):944-50.
1982: Baird A; Ling N; Böhlen P; Benoit R; Klepper R; Guillemin R
Molecular forms of the putative enkephalin precursor BAM-12P in bovine adrenal, pituitary, and hypothalamus.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(6):2023-5.
1982: Benoit R; Böhlen P; Ling N; Briskin A; Esch F; Brazeau P; Ying S Y; Guillemin R
Presence of somatostatin-28-(1-12) in hypothalamus and pancreas.
Proceedings of the National Academy of Sciences of the United States of America 1982;79(3):917-21.
1982: Ying S Y; Ling N C; Esch F S; Guillemin R; Watkins W B
Purification of gonadostatin from bovine seminal plasma (BSP).
Advances in experimental medicine and biology 1982;147():117-34.
1981: Böhlen P; Brazeau P; Esch F; Ling N; Guillemin R
Isolation and chemical characterization of somatostatin-28 from rat hypothalamus.
Regulatory peptides 1981;2(6):359-69.
1981: Guillemin R
Hypothalamic hypophysiotrophic peptides, known and unknown. The Sir Henry Dale lecture for 1980.
The Journal of endocrinology 1981;90(1):3p-10p.
1981: Böhlen P; Esch F; Shibasaki T; Baird A; Ling N; Guillemin R
Isolation and characterization of a gamma 1-melanotropin-like peptide from bovine neurointermediate pituitary.
FEBS letters 1981;128(1):67-70.
1981: Mandarino L; Stenner D; Blanchard W; Nissen S; Gerich J; Ling N; Brazeau P; Bohlen P; Esch F; Guillemin R
Selective effects of somatostatin-14, -25 and -28 on in vitro insulin and glucagon secretion.
Nature 1981;291(5810):76-7.
1981: Bohlen P; Benoit R; Ling N; Guillemin R; Brazeau P
Isolation and characterization of rat hypothalamic somatostatin-14.
Endocrinology 1981;108(5):2008-10.
1981: Shibasaki T; Ling N; Guillemin R; Silver M; Bloom F
The regional distribution of gamma 3-melanotropin-like peptides in bovine brain is correlated with adrenocorticotropin immunoreactivity but not with beta-endorphin.
Regulatory peptides 1981;2(1):43-52.
1981: Ying S Y; Ling N; Böhlen P; Guillemin R
Gonadocrinins: peptides in ovarian follicular fluid stimulating the secretion of pituitary gonadotropins.
Endocrinology 1981;108(4):1206-15.
1981: Lavielle S; Ling N C; Saltman R; Guillemin R C
Synthesis of a glycotripeptide and a glycosomatostatin containing the 3-O-(2-acetamido-2-deoxy-beta-D-glucopyranosyl)-L-serine residue.
Carbohydrate research 1981;89(2):229-36.
1981: Lavielle S; Ling N C; Guillemin R C
Solid-phase synthesis of two glycopeptides containing the amino acid sequence 5 to 9 of somatostatin.
Carbohydrate research 1981;89(2):221-8.
1981: Shibasaki T; Masui H; Sato G; Ling N; Guillemin R
Secretion pattern of pro-opiomelanocortin-derived peptides by a pituitary adenoma from a patient with Cushing's disease.
The Journal of clinical endocrinology and metabolism 1981;52(2):350-3.
1981: Brazeau P; Ling N; Esch F; Böhlen P; Benoit R; Guillemin R
High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25.
Regulatory peptides 1981;1(4):255-64.
1980: Jackson I M; Bolaffi J L; Guillemin R
Presence of immunoreactive beta-endorphin and enkephalin-like material in the retina and other tissues of the frog, Rana pipiens.
General and comparative endocrinology 1980;42(4):505-8.
1980: Bloom F E; Battenberg E L; Shibasaki T; Benoit R; Ling N; Guillemin R
Localization of gamma-melanocyte stimulating hormone (gamma MSH) immunoreactivity in rat brain and pituitary.
Regulatory peptides 1980;1(3):205-22.
1980: Benoit R; Böhlen P; Brazeau P; Ling N; Guillemin R
Isolation and characterization of rat pancreatic somatostatin.
Endocrinology 1980;107(6):2127-9.
1980: Esch F; Böhlen P; Ling N; Benoit R; Brazeau P; Guillemin R
Primary structure of ovine hypothalamic somatostatin-28 and somatostatin-25.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(11):6827-31.
1980: Böhlen P; Castillo F; Ling N; Guillemin R
Purification of peptides: an efficient procedure for the separation of peptides from amino acids and salt.
International journal of peptide and protein research 1980;16(4):306-10.
1980: Shibasaki T; Ling N; Guillemin R
A radioimmunoassay for gamma 1-melanotropin and evidence that the smallest pituitary gamma-melanotropin is amidated at the COOH-terminus.
Biochemical and biophysical research communications 1980;96(3):1393-9.
1980: Böhlen P; Brazeau P; Benoit R; Ling N; Esch F; Guillemin R
Isolation and amino acid composition of two somatostatin-like peptides from ovine hypothalamus: somatostatin-28 and somatostatin-25.
Biochemical and biophysical research communications 1980;96(2):725-34.
1980: Ling N; Esch F; Davis D; Mercado M; Regno M; Bohlen P; Brazeau P; Guillemin R
Solid phase synthesis of somatostatin-28.
Biochemical and biophysical research communications 1980;95(3):945-51.
1980: Oyama T; Matsuki A; Taneichi T; Ling N; Guillemin R
beta-Endorphin in obstetric analgesia.
American journal of obstetrics and gynecology 1980;137(5):613-6.
1980: Brazeau P; Ling N; Esch F; Bohlen P; Benoît R; Guillemin R
[High biological activity of the synthetic counterparts of hypothalamic somatostatin-28 and somatostatin-25]
Comptes rendus des séances de l'Académie des sciences. Série D, Sciences naturelles 1980;290(21):1369-71.
1980: Rossier J; Pittman Q; Bloom F; Guillemin R
Distribution of opioid peptides in the pituitary: a new hypothalamic-pars nervosa enkephalinergic pathway.
Federation proceedings 1980;39(8):2555-60.
1980: Shibasaki T; Ling N; Guillemin R
Pituitary immunoreactive gamma-melanotropins are glycosylated oligopeptides.
Nature 1980;285(5764):416-7.
1980: Shibasaki T; Ling N; Guillemin R
A radioimmunoassay for gamma-melanocyte stimulating hormone.
Life sciences 1980;26(21):1781-5.
1980: Julliard J H; Shibasaki T; Ling N; Guillemin R
High-molecular-weight immunoreactive beta-endorphin in extracts of human placenta is a fragment of immunoglobulin G.
Science (New York, N.Y.) 1980;208(4440):183-5.
1980: Rossier J; French E; Rivier C; Shibasaki T; Guillemin R; Bloom F E
Stress-induced release of prolactin: blockade by dexamethasone and naloxone may indicate beta-endorphin mediation.
Proceedings of the National Academy of Sciences of the United States of America 1980;77(1):666-9.
1980: Oyama T; Jin T; Yamaya R; Ling N; Guillemin R
Profound analgesic effects of beta-endorphin in man.
Lancet 1980;1(8160):122-4.
1980: Rossier J; French E; Guillemin R; Bloom F E
On the mechanisms of the simultaneous release of immunoreactive beta-endorphin, ACTH, and prolactin by stress.
Advances in biochemical psychopharmacology 1980;22():363-75.
1979: Rossier J; French E; Gros C; Minick S; Guillemin R; Bloom F E
Adrenalectomy, dexamethasone or stress alters opioid peptides levels in rat anterior pituitary but not intermediate lobe or brain.
Life sciences 1979;25(24-25):2105-12.
1979: Bayon A; Shoemaker W J; Bloom F E; Mauss A; Guillemin R
Perinatal development of the endorphin- and enkephalin-containing systems in the rat brain.
Brain research 1979;179(1):93-101.
1979: Lavielle S; Ling N; Brazeau P; Benoit R; Wasada T; Harris D; Unger R; Guillemin R
Synthesis and biological activity of glycosylated analogs of somatostatin.
Biochemical and biophysical research communications 1979;91(2):614-22.
1979: Ling N; Ying S; Minick S; Guillemin R
Synthesis and biological activity of four gamma-melanotropin peptides derived from the cryuptic region of the adrenocorticotropin/beta-lipotropin precursor.
Life sciences 1979;25(20):1773-9.
1979: Ying S Y; Guillemin R
[Gonadostatin and gonadocrinin, polypeptides of ovarian origin with hypophysiotropic activity]
Comptes rendus des séances de l'Académie des sciences. Série D, Sciences naturelles 1979;289(13):943-6.
1979: Shibasaki T; Deftos L; Guillemin R
Immunoreactive-beta-endorphin, -adrenocorticotropin and -calcitonin in extracts of anaplastic or differentiated (rat) medullary thyroid carcinoma.
Biochemical and biophysical research communications 1979;90(4):1266-73.
1979: Orloff M J; Hyde P V; Kosta L D; Guillemin R C; Bell R H
The intestinal phase hormone.
World journal of surgery 1979;3(5):523-38.
1979: Ying S Y; Guillemin R
DTrp6-Pro9-NEt)-luteinising hormone-releasing factor inhibits follicular development in hypophysectomised rats.
Nature 1979;280(5723):593-5.
1979: Guillemin R
Neuropeptides of the gut: a newly discovered major control system. Invited commentary.
World journal of surgery 1979;3(4):405-6.
1979: Chorev M; Shavitz R; Goodman M; Minick S; Guillemin R
Partially modified retro-inverso-enkephalinamides: topochemical long-acting analogs in vitro and in vivo.
Science (New York, N.Y.) 1979;204(4398):1210-2.
1979: Rossier J; Rogers J; Shibasaki T; Guillemin R; Bloom F E
Opioid peptides and alpha-melanocyte-stimulating hormone in genetically obese (ob/ob) mice during development.
Proceedings of the National Academy of Sciences of the United States of America 1979;76(4):2077-80.
1979: Ying S Y; Guillemin R
Dried Staphylococcus aureus as a rapid immunological separating agent in radioimmunoassays.
The Journal of clinical endocrinology and metabolism 1979;48(2):360-2.
1979: Rossier J; Battenberg E; Pittman Q; Bayon A; Koda L; Miller R; Guillemin R; Bloom F
Hypothalamic enkephalin neurones may regulate the neurohypophysis.
Nature 1979;277(5698):653-5.
1979: Hosobuchi Y; Rossier J; Bloom F E; Guillemin R
Stimulation of human periaqueductal gray for pain relief increases immunoreactive beta-endorphin in ventricular fluid.
Science (New York, N.Y.) 1979;203(4377):279-81.
1979: Guillemin R
New endocrinology of the brain.
Perspectives in biology and medicine 1979;22(2 Pt 2):S74-S80.
1978: Vale W; Rivier C; Yang L; Minick S; Guillemin R
Effects of purified hypothalamic corticotropin-releasing factor and other substances on the secretion of adrenocorticotropin and beta-endorphin-like immunoactivities in vitro.
Endocrinology 1978;103(5):1910-5.
1978: Guillemin R
Beta-lipotropin and endorphins: implications of current knowledge.
Hospital practice 1978;13(11):53-60.
1978: Henriksen S J; Bloom F E; McCoy F; Ling N; Guillemin R
beta-Endorphin induces nonconvulsive limbic seizures.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(10):5221-5.
1978: Guillemin R
Peptides in the brain: the new endocrinology of the neuron.
Science (New York, N.Y.) 1978;202(4366):390-402.
1978: Guillemin R
Some thoughts on current research with somatostatin.
Metabolism: clinical and experimental 1978;27(9 Suppl 1):1453-61.
1978: Deftos L J; Burton D; Catherwood B D; Bone H G; Parthemore J G; Guillemin R; Watkins W B; Moore R Y
Demonstration by immunoperoxidase histochemistry of calcitonin in the anterior lobe of the rat pituitary.
The Journal of clinical endocrinology and metabolism 1978;47(2):457-60.
1978: Guillemin R
The brain as an endocrine organ.
Neurosciences Research Program bulletin 1978;16 Suppl():1-25.
1978: Deftos L J; Burton D; Bone H G; Catherwood B D; Parthemore J G; Moore R Y; Minick S; Guillemin R
Immunoreactive calcitonin in the intermediate lobe of the pituitary gland.
Life sciences 1978;23(7):743-8.
1978: Ling N; Minick S; Guillemin R
Amino-terminal extension analogs of methionine-enkephalin.
Biochemical and biophysical research communications 1978;83(2):565-70.
1978: Bayon A; Rossier J; Mauss A; Bloom F E; Iversen L L; Ling N; Guillemin R
In vitro release of [5-methionine]enkephalin and [5-leucine]-enkephalin from the rat globus pallidus.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(7):3503-6.
1978: Orth D N; Guillemin R; Ling N; Nicholson W E
Immunoreactive endorphins, lipotropins and corticotropins in a human nonpituitary tumor: evidence for a common precursor.
The Journal of clinical endocrinology and metabolism 1978;46(5):849-52.
1978: Rossier J; Guillemin R; Bloom F
Foot shock induced stress decreases leu5-enkephalin immunoreactivity in rat hypothalamus.
European journal of pharmacology 1978;48(4):465-6.
1978: Bloom F; Battenberg E; Rossier J; Ling N; Guillemin R
Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: immunocytochemical studies.
Proceedings of the National Academy of Sciences of the United States of America 1978;75(3):1591-5.
1978: Guillemin R
[Peptides of cerebral origin. Their growing importance in physiology and medicine]
Bulletin der Schweizerischen Akademie der Medizinischen Wissenschaften 1978;34(1-3):63-78.
1978: Iversen L L; Iversen S D; Bloom F E; Vargo T; Guillemin R
Release of enkephalin from rat globus pallidus in vitro.
Nature 1978;271(5646):679-81.
1978: Hyde P V; Skivolocki W P; Guillemin R C; Sayers H J; Orloff M J
Augmentation of pentagastrin- and gastrin-stimulated acid secretion by the intestinal phase hormone.
Surgical forum 1978;29():392-4.
1978: Guillemin R
Biochemical and physiological correlates of hypothalamic peptides. The new endocrinology of the neuron.
Research publications - Association for Research in Nervous and Mental Disease 1978;56():155-94.
1978: Guillemin R
Control of adenohypophysial functions by peptides of the central nervous system.
Harvey lectures 1978;71():71-131.
1978: Bloom F E; Rossier J; Battenberg E L; Bayon A; French E; Henriksen S J; Siggins G R; Segal D; Browne R; Ling N; Guillemin R
beta-endorphin: cellular localization, electrophysiological and behavioral effects.
Advances in biochemical psychopharmacology 1978;18():89-109.
1977: Rossier J; French E D; Rivier C; Ling N; Guillemin R; Bloom F E
Foot-shock induced stress increases beta-endorphin levels in blood but not brain.
Nature 1977;270(5638):618-20.
1977: Weitzman R E; Fisher D A; Minick S; Ling N; Guillemin R
beta-Endorphin secretion of arginine vasopressin in vivo.
Endocrinology 1977;101(5):1643-6.
1977: Rossier J; Vargo T M; Minick S; Ling N; Bloom F E; Guillemin R
Regional dissociation of beta-endorphin and enkephalin contents in rat brain and pituitary.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(11):5162-5.
1977: Kan K W; Baird A; Seidah N G; Lis M; Chrétien M; Ling N; Guillemin R; Solomon S
Effects of peptides of pituitary origin on the formation of C21 steroid by fetal calf adrenal cells in culture.
Biochemical and biophysical research communications 1977;79(2):553-60.
1977: Segal D S; Browne R G; Bloom F; Ling N; Guillemin R
beta-Endorphin: endogenous opiate or neuroleptic?
Science (New York, N.Y.) 1977;198(4315):411-4.
1977: Guillemin R; Ling N; Lazarus L; Burgus R; Minick S; Bloom F; Nicoll R; Siggins G; Segal D
The endorphins, novel peptides of brain and hypophysial origin, with opiate-like activity: biochemical and biologic studies.
Annals of the New York Academy of Sciences 1977;297():131-57.
1977: Rossier J; Bayon A; Vargo T M; Ling N; Guillemin R; Bloom F
Radioimmunoassay of brain peptides: evaluation of a methodology for the assay of beta-endorphin and enkephalin.
Life sciences 1977;21(6):847-52.
1977: Gautray J P; Jolivet A; Vielh J P; Guillemin R
Presence of immunoassayable beta-endorphin in human amniotic fluid: elevation in cases of fetal distress.
American journal of obstetrics and gynecology 1977;129(2):211-2.
1977: Guillemin R
Purification, isolation, and primary structure of the hypothalamic luteinizing hormone-releasing factor of ovine origin. A historical account.
American journal of obstetrics and gynecology 1977;129(2):214-8.
1977: Guillemin R; Vargo T; Rossier J; Minick S; Ling N; Rivier C; Vale W; Bloom F
beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland.
Science (New York, N.Y.) 1977;197(4311):1367-9.
1977: Janowsky D S; Segal D S; Bloom F; Abrams A; Guillemin R
Lack of effect on naloxone on schizophrenic symptoms.
The American journal of psychiatry 1977;134(8):926-7.
1977: Janowsky D S; Segal D S; Abrams A; Bloom F; Guillemin R
Negative naloxone effects in schizophrenic patients.
Psychopharmacology 1977;53(3):295-7.
1977: Guillemin R; Ling N; Vargo T
Radioimmunoassays for alpha-endorphin and beta-endorphin.
Biochemical and biophysical research communications 1977;77(1):361-6.
1977: Nicoll R A; Siggins G R; Ling N; Bloom F E; Guillemin R
Neuronal actions of endorphins and enkephalins among brain regions: a comparative microiontophoretic study.
Proceedings of the National Academy of Sciences of the United States of America 1977;74(6):2584-8.
1977: Bloom F; Battenberg E; Rossier J; Ling N; Leppaluoto J; Vargo T M; Guillemin R
Endorphins are located in the intermediate and anterior lobes of the pituitary gland, not in the neurohypophysis.
Life sciences 1977;20(1):43-7.
1977: Guillemin R
Endorphins, brain peptides that act like opiates.
The New England journal of medicine 1977;296(4):226-8.
1977: Rivier C; Vale W; Ling N; Brown M; Guillemin R
Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin.
Endocrinology 1977;100(1):238-41.
1977: Guillemin R; Ling N; Burgus R; Bloom F; Segal D
Characterization of the endorphins, novel hypothalamic and neurohypophysial peptides with opiate-like activity: evidence that they induce profound behavioral changes.
Psychoneuroendocrinology 1977;2(1):59-62.
1977: Guillemin R; Estibal H; Bonelli A J
[Trial use of aescine by drug dielectrolysis--apropos of 80 cases]
Electrodiagnostic-Thérapie 1977;14(2):51-4.
1977: Commandre F; Guillemin R; Revelli G
[Electrotherapy in inflammatory osteo-articular reactions]
Electrodiagnostic-Thérapie 1977;14(2):37-49.
1977: Commandre F; Kalaschnikoff P; Auzias J; Guillemin R; Viani J L; Lengrand J; Mercati E
[Reflex algoneurodystrophies and high-frequency pulsations]
Electrodiagnostic-Thérapie 1977;14(1):9-18.
1977: Guillemin R; Commandre F; Bonelli A J
[Electrotherapy in circulatory disorders of the legs]
Electrodiagnostic-Thérapie 1977;14(1):5-8.
1977: Guillemin R
The endocrinology of the neuron and the neural origin of endocrine cells.
Advances in experimental medicine and biology 1977;87():1-12.
1976: Guillemin R
Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus.
Endocrinology 1976;99(6):1653-4.
1976: Ling N; Burgus R; Guillemin R
Isolation, primary structure, and synthesis of alpha-endorphin and gamma-endorphin, two peptides of hypothalamic-hypophysial origin with morphinomimetic activity.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(11):3942-6.
1976: Bloom F; Segal D; Ling N; Guillemin R
Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness.
Science (New York, N.Y.) 1976;194(4265):630-2.
1976: Ling N; Guillemin R
Morphinomimetic activity of synthetic fragments of beta-lipotropin and analogs.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(9):3308-10.
1976: Orci L; Baetens O; Rufener C; Brown M; Vale W; Guillemin R
Evidence for immunoreactive neurotensin in dog intestinal mucosa.
Life sciences 1976;19(4):559-61.
1976: Lazarus L H; Ling N; Guillemin R
beta-Lipotropin as a prohormone for the morphinomimetic peptides endorphins and enkephalins.
Proceedings of the National Academy of Sciences of the United States of America 1976;73(6):2156-9.
1976: Guillemin R; Ling N; Burgus R
[Endorphins, hypothalamic and neurohypophysial peptides with morphinomimetic activity: isolation and molecular structure of alpha-endorphin]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1976;282(8):783-5.
1976: Guillemin R
Physiological and clinical significance of hypothalamic and extrahypothalamic brain peptides.
Triangle; the Sandoz journal of medical science 1976;15(1):1-7.
1976: Guillemin R; Gerich J E
Somatostatin: physiological and clinical significance.
Annual review of medicine 1976;27():379-88.
1976: Guillemin R
The expanding significance of hypothalamic peptides, or, is endocrinology a branch of neuroendocrinology?
Recent progress in hormone research 1976;33():1-28.
1975: Brown M; Rivier J; Vale W; Guillemin R
Variability of the duration of inhibition of growth hormone release by Nalpha-acylated-des-(Ala1-Gly2)-H2somatostatin analogs.
Biochemical and biophysical research communications 1975;65(2):752-6.
1975: Guillemin R; Fontaine M
[The historic role of insulin in the physiopathology of the metabolic complications from pancreatic diabetes. Therapeutic implications for somatostatin]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1975;280(20):2353-6.
1975: Gerich J E; Lorenzi M; Hane S; Gustafson G; Guillemin R; Forsham P H
Evidence for a physiologic role of pancreatic glucagon in human glucose homeostasis: studies with somatostatin.
Metabolism: clinical and experimental 1975;24(2):175-82.
1975: Rivier J; Brazeau P; Vale W; Guillemin R
Somatostatin analogs. Relative importance of the disulfide bridge and of the Ala-Gly side chain for biological activity.
Journal of medicinal chemistry 1975;18(2):123-6.
1975: Guillemin R
Significance of somatostatin, newcomer from the hypothalamus.
Voprosy biokhimii mozga 1975;10():117-21.
1975: Vale W; Brazeau P; Rivier C; Brown M; Boss B; Rivier J; Burgus R; Ling N; Guillemin R
Somatostatin.
Recent progress in hormone research 1975;31():365-97.
1974: Brazeau P; Vale W; Burgus R; Guillemin R
Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin.
Canadian journal of biochemistry 1974;52(11):1067-72.
1974: Gerich J E; Lorenzi M; Schneider V; Kwan C W; Karam J H; Guillemin R; Forsham P H
Inhibition of pancreatic glucagon responses to arginine by somatostatin in normal man and in insulin-dependent diabetics.
Diabetes 1974;23(11):876-80.
1974: Brazeau P; Vale W; Rivier J; Guillemin R
Acylated des-(Ala1-Gly2)-somatostatin analogs: prolonged inhibition of growth hormone secretion.
Biochemical and biophysical research communications 1974;60(4):1202-7.
1974: Peterson R E; Guillemin R
The hormones of the hypothalamus.
The American journal of medicine 1974;57(4):591-600.
1974: Vale W; Rivier C; Brazeau P; Guillemin R
Effects of somatostatin on the secretion of thyrotropin and prolactin.
Endocrinology 1974;95(4):968-77.
1974: Luft R; Guillemin R
Growth hormone and diabetes in man. Old concepts--new implications.
Diabetes 1974;23(9):783-7.
1974: Gerich J E; Lorenzi M; Schneider V; Karam J H; Rivier J; Guillemin R; Forsham P H
Effects of somatostatin on plasma glucose and glucagon levels in human diabetes mellitus. Pathophysiologic and therapeutic implications.
The New England journal of medicine 1974;291(11):544-7.
1974: Brazeau P; Vale W; Rivier J; Guillemin R
Biological potency of synthetic somatostatin in the oxidized and reduced form on the inhibition of secretion of growth hormone.
Life sciences 1974;15(2):351-7.
1974: Siler T M; Yen S C; Vale W; Guillemin R
Inhibition by somatostatin on the release of TSH induced in man by thyrotropin-releasing factor.
The Journal of clinical endocrinology and metabolism 1974;38(5):742-5.
1974: Parker D C; Rossman L G; Siler T M; Rivier J; Yen S S; Guillemin R
Inhibition of the sleep-related peak in physiologic human growth hormone release by somatostatin.
The Journal of clinical endocrinology and metabolism 1974;38(3):496-9.
1974: Brazeau P; Rivier J; Vale W; Guillemin R
Inhibition of growth hormone secretion in the rat by synthetic somatostatin.
Endocrinology 1974;94(1):184-7.
1974: Guillemin R
The hormones of the hypothalamus.
Progress in brain research 1974;41():117-32.
1973: Ling N; Rivier J; Burgus R; Guillemin R
Direct sequence determination of ovine luteinizing hormone releasing factor by mass spectrometry.
Biochemistry 1973;12(26):5305-10.
1973: Siler T M; VandenBerg G; Yen S S; Brazeau P; Vale W; Guillemin R
Inhibition of growth hormone release in humans by somatostatin.
The Journal of clinical endocrinology and metabolism 1973;37(4):632-4.
1973: Guillemin R; Amoss M; Blackwell R; Burgus R; Grant G; Ling N; Monahan M; Rivier J; Vale W
Polypeptide antagonists of the hypothalamic luteinizing hormone releasing factors.
Journal of reproduction and fertility. Supplement 1973;18():23-30.
1973: Vale W; Blackwell R; Grant G; Guillemin R
TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro.
Endocrinology 1973;93(1):26-33.
1973: Grant G; Vale W; Guillemin R
Characteristics of the pituitary binding sites for thyrotropin releasing factor.
Endocrinology 1973;92(6):1629-33.
1973: Rivier J; Vale W; Burgus R; Ling N; Amoss M; Blackwell R; Guillemin R
Synthetic luteinizing hormone-releasing factor analogs. Series of short-chain amide LRF homologs converging to the amino terminus.
Journal of medicinal chemistry 1973;16(5):545-9.
1973: Rivier J; Brazeau P; Vale W; Ling N; Burgus R; Gilon C; Yardley J; Guillemin R
[Solid-phase total synthesis of a tetradecapeptide having the chemical and biological properties of somatostatine]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1973;276(19):2737-40.
1973: Burgus R; Ling N; Butcher M; Guillemin R
Primary structure of somatostatin, a hypothalamic peptide that inhibits the secretion of pituitary growth hormone.
Proceedings of the National Academy of Sciences of the United States of America 1973;70(3):684-8.
1973: Rivier C; Vale W; Guillemin R
An in vivo corticotropin-releasing factor (CRF) assay based on plasma levels of radioimmunoassayable ACTH.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;142(3):842-5.
1973: Blackwell R; Vale W; Rivier C; Guillemin R
Effect of perphenazine on the secretion of prolactin in vivo and in vitro.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1973;142(1):68-71.
1973: Brazeau P; Vale W; Burgus R; Ling N; Butcher M; Rivier J; Guillemin R
Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone.
Science (New York, N.Y.) 1973;179(68):77-9.
1973: Blackwell R; Vale W; Amoss M; Burgus R; Monahan M; Rivier J; Ling N; Guillemin R
Lack of effect of native or synthetic LRF on secretion of prolactin in vitro.
The American journal of physiology 1973;224(1):176-9.
1973: Blackwell R; Amoss M; Vale W; Burgus R; Rivier J; Monahan M; Ling N; Guillemin R
Concomitant release of FSH and LH induced by native and synthetic LRF.
The American journal of physiology 1973;224(1):170-5.
1973: Rebar R; Yen S S; VandenBerg G; Naftolin F; Ehara Y; Engblom S; Ryan K J; Amoss M; Guillemin R
Gonadotropin responses to synthetic LRF: dose-response relationship in men.
The Journal of clinical endocrinology and metabolism 1973;36(1):10-6.
1973: Guillemin R; Vale W; Grant G
Chemistry of the hypothalamic releasing factors. Studies on structure-function relationships in TRF and LRF.
Voprosy biokhimii mozga 1973;8():141-76.
1973: Vale W; Grant G; Guillemin R
Chemistry of the hypothalamic releasing factors--studies on structure-function relationships.
Frontiers in neuroendocrinology 1973;0(0):375-413.
1973: Blackwell R E; Guillemin R
Hypothalamic control of adenohypophysial secretions.
Annual review of physiology 1973;35():357-90.
1973: Burgus R; Vale W; Rivier J; Monahan M; Ling N; Grant G; Amoss M; Guillemin R
Chemistry of hypothalamic releasing factors.
Progress in brain research 1973;39():41-51.
1972: Vale W; Brazeau P; Grant G; Nussey A; Burgus R; Rivier J; Ling N; Guillemin R
[Preliminary observations on the mechanism of action of somatostatin, a hypothalamic factor inhibiting the secretion of growth hormone]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1972;275(25):2913-6.
1972: Guillemin R; Burgus R
The hormones of the hypothalamus.
Scientific American 1972;227(5):24-33.
1972: Guillemin R; Amoss M; Blackwell R; Rivier J; Ling N; Vale W
On the biological activities of the synthetic tetrapeptide pyroglutamyl-tyrosyl-arginyl-tryptophanyl-amide.
Biochemical and biophysical research communications 1972;48(5):1093-9.
1972: Vale W; Grant G; Amoss M; Blackwell R; Guillemin R
Culture of enzymatically dispersed pituitary cells: functional validation of a method.
Endocrinology 1972;91(2):562-72.
1972: Amoss M; Rivier J; Guillemin R
Release of gonadotropins by oral administration of synthetic LRF or a tripeptide fragment of LRF.
The Journal of clinical endocrinology and metabolism 1972;35(1):175-7.
1972: Yen S S; Rebar R; Van den Berg G; Naftolin F; Ehara Y; Engblom S; Ryan K J; Benirschke K; Rivier J; Amoss M; Guillemin R
Synthetic luteinizing hormone-releasing factor. A potent stimulator of gonadotropin release in man.
The Journal of clinical endocrinology and metabolism 1972;34(6):1108-11.
1972: Monahan M W; Rivier J; Vale W; Guillemin R; Burgus R
(Gly 2 )LRF and des-His 2 -LRF. The synthesis, purification, and characterization of two LRF analogues antagonistic to LRF.
Biochemical and biophysical research communications 1972;47(3):551-6.
1972: Vale W; Grant G; Rivier J; Monahan M; Amoss M; Blackwell R; Burgus R; Guillemin R
Synthetic polypeptide antagonists of the hypothalamic luteinizing hormone releasing factor.
Science (New York, N.Y.) 1972;176(37):933-4.
1972: Amoss M; Blackwell R; Guillemin R
Stimulation of ovulation in the rabbit triggered by synthetic LRF.
The Journal of clinical endocrinology 1972;34():434-6.
1972: Amoss M; Blackwell R; Guillemin R
Stimulation of ovulation in the rabbit triggered by synthetic LRF.
The Journal of clinical endocrinology and metabolism 1972;34(2):434-6.
1972: Grant G; Vale W; Guillemin R
Interaction of thyrotropin releasing factor with membrane receptors of pituitary cells.
Biochemical and biophysical research communications 1972;46(1):28-34.
1972: Guillemin R
Physiology and chemistry of the hypothalamic releasing factors for gonadotropins: a new approach to fertility control.
Contraception 1972;5(1):1-19.
1972: Burgus R; Butcher M; Amoss M; Ling N; Monahan M; Rivier J; Fellows R; Blackwell R; Vale W; Guillemin R
Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation).
Proceedings of the National Academy of Sciences of the United States of America 1972;69(1):278-82.
1972: Fleischer N; Guillemin R
Clinical applications of hypothalamic-releasing factors.
Advances in internal medicine 1972;18():303-23.
1971: Burgus R; Butcher M; Ling N; Monahan M; Rivier J; Fellows R; Amoss M; Blackwell R; Vale W; Guillemin R
[Molecular structure of the hypothalamic factor (LRF) of ovine origin monitoring the secretion of pituitary gonadotropic hormone of luteinization (LH)]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1971;273(18):1611-3.
1971: Porter J C; Vale W; Burgus R; Mical R S; Guillemin R
Release of TSH by TRF infused directly into a pituitary stalk portal vessel.
Endocrinology 1971;89(4):1054-6.
1971: Monahan M; Rivier J; Burgus R; Amoss M; Blackwell R; Vale W; Guillemin R
[Total synthesis by solid phase of a decapeptide stimulating the secretion of LH and FSH pituitary gonadotropins]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1971;273(4):508-10.
1971: Amoss M; Burgus R; Blackwell R; Vale W; Fellows R; Guillemin R
Purification, amino acid composition and N-terminus of the hypothalamic luteinizing hormone releasing factor (LRF) of ovine origin.
Biochemical and biophysical research communications 1971;44(1):205-10.
1971: Vale W W; Burgus R; Dunn T F; Guillemin R
In vitro plasma inactivation of thyrotropin releasing factor (TRF) and related peptides. Its inhibition by various means and by the synthetic dipeptide PCA-His-OME.
Hormones 1971;2(4):193-203.
1971: Guillemin R; Burgus R; Vale W
The hypothalamic hypophysiotropic thyrotropin-releasing factor.
Vitamins and hormones 1971;29():1-39.
1971: Guillemin R; Amoss M; Blackwell R; Burgus R; Grant G; Ling N; Monahan M; Rivier J; Vale W
Polypeptides antagonists of the hypothalamic luteinizing hormone releasing factor.
Gynecologic investigation 1971;2(1):2-12.
1971: Guillemin R
Hypothalamic control of the secretion of adenohypophysial hormones.
Advances in metabolic disorders 1971;5():1-51.
1970: Fleischer N; Burgus R; Vale W; Dunn T; Guillemin R
Preliminary observations on the effect of synthetic thyrotropin releasing factor on plasma thyrotropin levels in man.
The Journal of clinical endocrinology and metabolism 1970;31(1):109-12.
1970: Burgus R; Dunn T F; Desiderio D; Ward D N; Vale W; Guillemin R
Characterization of ovine hypothalamic hypophysiotropic TSH-releasing factor.
Nature 1970;226(5243):321-5.
1970: Burgus R; Dunn T F; Desiderio D M; Ward D N; Vale W; Guillemin R; Felix A M; Gillessen D; Studer R O
Biological activity of synthetic polypeptide derivatives related to the structure of hypothalamic TRF.
Endocrinology 1970;86(3):573-82.
1970: Vale W; Burgus R; Dunn T F; Guillemin R
Release of TSH by oral administration of synthetic peptide derivatives with TRF activity.
The Journal of clinical endocrinology and metabolism 1970;30(1):148-50.
1970: Burgus R; Guillemin R
Hypothalamic releasing factors.
Annual review of biochemistry 1970;39():499-526.
1969: Burgus R; Dunn T F; Desiderio D; Guillemin R
[Molecular structure of the hypothalamic hypophysiotropic TRF factor of ovine origin: mass spectrometry demonstration of the PCA-His-Pro-NH2 sequence]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1969;269(19):1870-3.
1969: Burgus R; Dunn T F; Desiderio D; Vale W; Guillemin R
[Synthetic polypeptide derivatives with TRF hypophysiotropic activity. New data]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1969;269(2):226-8.
1969: Guillemin R
[Chymotrypsin in rheumatology. propos of372 cases]
Therapeutique (La Semaine des hôpitaux) 1969;45(6):639-43.
1969: Amoss M S; Guillemin R
Elevation of plasma LH concentrations induced by LH-releasing factor as measured by radioimmunoassay in the sheep.
Endocrinology 1969;84(6):1517-20.
1969: Rodger N W; Beck J C; Burgus R; Guillemin R
Variability of response in the bioassay for a hypothalamic somatotrophin releasing factor based on rat pituitary growth hormone content.
Endocrinology 1969;84(6):1373-83.
1969: Burgus R; Dunn T F; Ward D N; Vale W; Amoss M; Guillemin R
[Synthetic polypeptide derivatives with thyrotropin releasing factor hypophysiotropic activity]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1969;268(16):2116-8.
1967: Vale W; Guillemin R
Potassium-induced stimulation of thyrotropin release in vitro. Requirement for presence of calcium and inhibition by thyroxine.
Experientia 1967;23(10):855-7.
1967: Vale W; Burgus R; Guillemin R
Presence of calcium ions as a requisite for the in vitro stimulation of TSH-release by hypothalamic TRF.
Experientia 1967;23(10):853-5.
1967: Guillemin R
Chemistry and physiology of hypothalamic releasing factors for gonadotrophins.
International journal of fertility 1967;12(4):359-67.
1967: Guillemin R
Hypothalamic control of concomitant secretion of ACTH and TSH.
Proceedings of the Royal Society of Medicine 1967;60(9):903.
1967: Burgus R; Amoss M S; Guillemin R
Solubility of the hypothalamic hormones TSH-releasing factor (TRF) and LH-releasing factor (LRF) in organic and alcoholic solvents.
Experientia 1967;23(6):417-8.
1967: Vale W; Burgus R; Guillemin R
Competition between thyroxine and TRF at the pituitary level in the release of TSH.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1967;125(1):210-3.
1967: Ducommun P; Vale W; Sakiz E; Guillemin R
Reversal of the inhibition of TSH secretion due to acute stress.
Endocrinology 1967;80(5):953-6.
1967: Guillemin R
The adenohypophysis and its hypothalamic control.
Annual review of physiology 1967;29():313-48.
1966: Ducommun S; Guillemin R
Maintenance of normal morphology in adenohypophysial transplants by topical administration of hypothalamic extracts with a simple method for transplantation in a pneumoderma pouch.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1966;122(4):1251-5.
1966: Burgus R; Ward D N; Sakiz E; Guillemin R
[Action of proteolytic enzymes on purified preparations of the TSH-hypophysiotropic hypothalamic hormone, TRF]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1966;262(25):2643-5.
1966: Ducommun P; Sakiz E; Guillemin R
Dissociation of the acute secretions of thyrotropin and adrenocorticotropin.
The American journal of physiology 1966;210(6):1257-9.
1966: Guillemin R; Burgus R; Sakiz E; Ward D N
[Further data on the purification of the TSH-hypophysiotropic hypothalamic hormone, TRF]
Comptes rendus hebdomadaires des séances de l'Académie des sciences. Série D: Sciences naturelles 1966;262(21):2278-80.
1966: Ducommun P; Sakiz E; Guillemin R
Lability of plasma TSH levels in the rat in response to nonspecific exteroceptive stimuli.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1966;121(3):921-3.
1965: Berato J; Commandre F; Gilly R W; Guillemin R; Lapras P; Daumas B
[The corticotherapeutic escalade]
Rhumatologie 1965;17(9):349-52.
1965: Ducommun P; Sakiz E; Guillemin R
Increase of plasma TSH concentration following injection of purified hypothalamic TRF.
Endocrinology 1965;77(5):792-6.
1965: Sakiz E; Guillemin R
Inverse effects of purified hypothalamic TRF on the acute secretion of TSH and ACTH.
Endocrinology 1965;77(5):797-801.
1965: Guillemin R; Ward D N; Sakiz E
Filtration chromatography on substituted Sephadex in the purification of the hypothalamic hormone TRF (TSH-releasing factor).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1965;120(1):256-8.
1965: Guillemin R; Sakiz E
A proposal for a reference standard preparation for the hypothalamic thyrotrophic hormone releasing factor.
Nature 1965;207(994):297-8.
1965: GUILLEMIN R; SAKIZ E; WARD D N
FURTHER PURIFICATION OF TSH-RELEASING FACTOR (TRF) FROM SHEEP HYPOTHALAMIC TISSUES, WITH OBSERVATIONS ON THE AMINO ACID COMPOSITION.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1965;118():1132-7.
1965: HOFF H E; GUILLEMIN R; SAKIZ E
CLAUDE BERNARD ON ANIMAL HEAT--AN UNPUBLISHED MANUSCRIPT AND SOME ORIGINAL NOTES.
Perspectives in biology and medicine 1965;8():347-68.
1965: Guillemin R
[Biochemistry and physiology of hypothalamic hormones]
Verhandlungen der Deutschen Gesellschaft für Innere Medizin 1965;71():61-6.
1964: GUILLEMIN R
HYPOTHALAMIC POLYPEPTIDES RELEASING PITUITARY HORMONES.
Metabolism: clinical and experimental 1964;13():SUPPL:1206-10.
1964: SAKIZ E; GUILLEMIN R
[POTENTIATION OF THE BIOLOGICAL ACTION OF THE LRF HYPOTHALAMIC FACTOR OF BOVINE OR OVINE ORIGIN BY SYNTHETIC ARGININE-VASOPRESSIN.]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1964;259():237-40.
1964: GUILLEMIN R; SAKIZ E; WARD D N
[PURIFICATION OF THE HYPOTHALAMIC FACTOR (TRF) STIMULATING THE SECRETION OF THE THYROTROPIC PITUITARY HORMONE (TSH) BY THE COUNTER-CURRENT DISTRIBUTION METHOD.]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1964;258():6567-8.
1964: SAKIZ E; GUILLEMIN R
ON A METHOD FOR CALCULATION AND ANALYSIS OF RESULTS IN THE MCKENZIE ASSAY FOR THYROTROPIN (TSH).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1964;115():856-60.
1964: SCHALLY A V; GUILLEMIN R
SOME BIOLOGICAL AND CHEMICAL PROPERTIES OF A LYSINE- VASOPRESSIN DIMER.
The Journal of biological chemistry 1964;239():1038-41.
1964: GUILLEMIN R
HYPOTHALAMIC FACTORS RELEASING PITUITARY HORMONES.
Recent progress in hormone research 1964;20():89-130.
1964: LAPEYRE L; COMMANDRE F; GUILLEMIN R; BERATO J; CREISSON G
[BRUCELLAR SPONDYLO-DISKITIS. GENERAL REVIEW APROPOS OF 4 OBSERVATIONS.]
Marseille médical 1964;101():915-24.
1964: HOFF H E; GUILLEMIN R; SAKIZ E
CLAUDE BERNARD ON EXPERIMENTAL MEDICINE. SOME UNPUBLISHED NOTES.
Perspectives in biology and medicine 1964;8():30-49.
1963: SCHIAVI R; JUTISZ M; SAKIZ E; GUILLEMIN R
STIMULATION OF OVULATION BY PURIFIED LH-RELEASING FACTOR (LRF) IN ANIMALS RENDERED ANOVULATORY BY HYPOTHALAMIC LESION.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1963;114():426-9.
1963: GUILLEMIN R; YAMAZAKI E; GARD D A; JUTISZ M; SAKIZ E
IN VITRO SECRETION OF THYROTROPIN (TSH): STIMULATION BY A HYPOTHALAMIC PEPTIDE (TRF).
Endocrinology 1963;73():564-72.
1963: CLAYTON G W; LIBRIK L; GARDNER R L; GUILLEMIN R
STUDIES ON THE CIRCADIAN RHYTHM OF PITUITARY ADRENOCORTICOTROPIC RELEASE IN MAN.
The Journal of clinical endocrinology and metabolism 1963;23():975-80.
1963: LAPEYRE L; COMMANDRE F; BARALIS G; TARAMASCO H; GUILLEMIN R
[SYMPATHETIC NEURO-OSTEO-TROPHIC SYNDROME CAUSED BY ZONA. GENERAL OBSERVATIONS ON A NEW CASE.]
Rhumatologie 1963;15():227-37.
1963: YAMAZAKI E; SAKIZ E; GUILLEMIN R
[CONCERNING THE EFFECT OF MELANOPHORETIC HORMONES ALPHA-MSH AND BETA-MSH ON THYROTROPIC AND THYROID FUNCTIONS.]
Annales d'endocrinologie 1963;24():795-800.
1963: YAMAZAKI E; SAKIZ E; GUILLEMIN R
AN IN VIVO BIOASSAY FOR TSH-RELEASING FACTOR (TRF).
Experientia 1963;19():480-1.
1963: COURRIER R; COLONGE A; SAKIZ E; GUILLEMIN R; JUTISZ M
[PRESENCE IN A SALINE EXTRACT OF HYPOTHALAMUS OF AN RSH TYPE FOLLICLE-STIMULATING ACTIVITY.]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1963;257():1206-10.
1963: JUTISZ M; DE LA LLOSA P; SAKIZ E; YAMAZAKI E; GUILLEMIN R
[Action of proteolytic enzymes on hypothalamic factors LRF and TRF stimulating the secretion of pituitary luteinizing (LH) and thyrotropic (TSH) hormones.]
Comptes rendus des séances de la Société de biologie et de ses filiales 1963;157():235-7.
1963: SAKIZ E; GUILLEMIN R
On the method of ovarian ascorbic acid depletion as a test for luteinizing hormone (LH).
Endocrinology 1963;72():804-12.
1963: GUILLEMIN R; SAKIZ E
Quantitative study of the response to LH after hypophysectomy in the ovarian ascorbic acid depletion test: effect of prolactin.
Endocrinology 1963;72():813-6.
1963: SCHALLY A V; GUILLEMIN R
Isolation and chemical characterization of a beta-CRF from pig posterior pituitary glands.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1963;112():1014-7.
1963: HOFF H E; GUILLEMIN R
The first experiments on transfusion in France.
Jornal de historia da medicina 1963;18():103-24.
1963: JUTISZ M; YAMAZAKIE; BERAULT A; SAKIZ E; GUILLEMIN R
[Purification by carboxymethylcellulose chromatography of an hypothalamic factor (TRF) stimulating the secretion of thyrotropic pituitary hormone (TSH).]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1963;256():2925-7.
1963: JUTISZ M; YAMAZAKIE; BERAULT A; SAKIZ E; GUILLEMIN R
[Purification by carboxymethylcellulose chromatography of an hypothalamic factor (TRF) stimulating the secretion of thyrotropic pituitary hormone (TSH).]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1963;256():2925-7.
1963: GUILLEMIN R
[Recent information on neuroendocrine chemical mediators originating in the central nervous system.]
Bratislavské lekárske listy 1963;43():129-36.
1963: CRITCHLOW V; LIPSCOMB H S; GUILLEMIN R
Effect of CRF on maintenance of the adrenocorticotrophic function of anterior pituitary grafts.
The Journal of endocrinology 1963;25():465-72.
1963: GUILLEMIN R; JUTISZ M; SAKIZ E
[The partial purification of an hypothalamic factor (LRF) stimulating the secretion of pituitary luteinizing hormone (LH).]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1963;256():504-7.
1963: GUILLEMIN R; SCHALLY A V
CONCENTRATION OF CORTICOTROPIN RELEASING FACTOR (CRF) IN ACID EXTRACTS OF SHEEP HYPOTHALAMUS BY GEL FILTRATION AND COUNTER CURRENT DISTRIBUTION.
Texas reports on biology and medicine 1963;21():541-5.
1963: GUILLEMIN R
[On the nature of hypothalamic substances which control the secretion of anterior pituitary hormones.]
Journal de physiologie 1963;55():7-44.
1963: GUILLEMIN R
Hypothalamic neurohumors in the control of the functions of the anterior hypophysis.
Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie 1963;245():187-96.
1963: GILLY R W; RENAULT B; SICARD D; WIART M; GUILLEMIN R; BERATO
[Apropos of a case of myeloid splenomegaly with acute blastic transformation.]
Marseille médical 1963;100():59-62.
1962: SCHALLY A V; LIPSCOMB H S; GUILLEMIN R
Isolation and amino acid sequence of alpha2-corticotropin-releasing factor (alpha2-CRF) from hog pituitary glands.
Endocrinology 1962;71():164-73.
1962: WARD D N; WALBORG E F; LIPSCOMB H S; GUILLEMIN R
Fractionation and analysis of monkey pituitary glands for posterior lobe hormones.
Acta endocrinologica 1962;40():283-9.
1962: SAKIZ E; GUILLEMIN R
[Routine use of a large electronic computer in the mathematical analysis of results in experimental biology.]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1962;254():3743-5.
1962: SCHALLY A V; LIPSCOMB H S; LONG J M; DEAR W E; GUILLEMIN R
Chromatography and hormonal activities of dog hypothalamus.
Endocrinology 1962;70():478-80.
1962: GUILLEMIN R; SCHALLY A V; LIPSCOMB H S; ANDERSEN R N; LONG J M
On the presence in hog hypothalamus of 3-corticotropin releasing factor, alpha- and beta-melanocyte stimulating hormones, adrenocorticotropin, lysine-vasopressin and oxytocin.
Endocrinology 1962;70():471-7.
1962: GUILLEMIN R; COLONGE A; JUTISZ M; SAKIZ E
[Persistence of the biological activity of the luteinizing hormone after heating to 100 degrees C in an acid medium.]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1962;254():3258-60.
1962: KRIVOY W A; GUILLEMIN R
Antagonism of chlorpromazine by beta-melanocyte stimulating hormone (beta-MSH).
Experientia 1962;18():20-1.
1962: MOUREN P; PASTOR J; GUILLEMIN R
[Acute porphyria with neurological manifestations in the course of 3 generations. Clinical and biological findings.]
Marseille médical 1962;99():116-9.
1962: SCHALLY A V; ROBINSON S; GUILLEMIN R
Quantitative aspects of percolation for the extraction of oxytocin and vasopressin.
Texas reports on biology and medicine 1962;20():680-2.
1961: LIEBELT R A; DEAR W; GUILLEMIN R
Goldthioglucose-induced hypothalamic lesion and ACTH release.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1961;108():377-80.
1961: LONG J M; KRIVOY W A; GUILLEMIN R
On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the Mammalia: enzymatic inactivation in vitro of beta-MSH by brain tissue.
Endocrinology 1961;69():176-81.
1961: KRIVOY W A; GUILLEMIN R
On a possible role of beta-melanocyte stimulating hormone (beta-MSH) in the central nervous system of the Mammalia: an effect of beta-MSH in the spinal cord of the cat.
Endocrinology 1961;69():170-5.
1961: COURRIER R; GUILLEMIN R; COLONGE A; SAKIZ E
[Adrenal cortical response to hypophysial corticotropin hormone in the rat, as a function of sex. In vivo study.]
Comptes rendus des séances de la Société de biologie et de ses filiales 1961;252():3520-4.
1961: LONG J M; GUILLEMIN R
On the in vitrobioassay for measuring melanophoretic activity.
Experientia 1961;17():132-4.
1961: GUILLEMIN R; SCHALLY A V
On the nature of the hypothalamic substance which controls the secretion of ACTH.
Acta neurovegetativa 1961;23():58-62.
1960: SCHALLY A V; ANDERSEN R N; LIPSCOMB H S; LONG J M; GUILLEMIN R
Evidence for the existence of two corticotrophin-releasing factors, alpha and beta.
Nature 1960;188():192-3.
1960: GUILLEMIN R
[Neurohumoral control of hypophysial adrenocorticotropic function.]
Schweizerische medizinische Wochenschrift 1960;90():1328-9.
1960: SCHALLY A V; ANDERSEN R N; LONG J M; GUILLEMIN R
Isolation of alpha- and beta-melanocyte stimulating hormones (MSH) on a preparative scale.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1960;104():290-3.
1960: GUILLEMIN R
Steroidogenic activities of purified alpha, beta, gamma, delta-corticotropins and pepsin degradation products of beta-corticotropin.
Endocrinology 1960;66():819-23.
1960: GUILLEMIN R; SCHALLY A; ANDERSEN R; LIPSCOMB H; LONG J
[On the existence of 2 types of substances with hypophysiotropic activity: a-CRF and beta-CRF (corticotrophin-releasing factor).]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1960;250():4462-4.
1960: GUILLEMIN R; KRIVOY W A
[Does the melanophoretic hormone beta-MSH play a role in the functions of the central nervous system in the higher mammals?]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1960;250():1117-9.
1960: DEAR W E; GUILLEMIN R
Adrenal sensitivity to ACTH as a function of time after hypothalamic lesion and after hypophysectomy.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1960;103():356-8.
1960: SCHALLY A V; GUILLEMIN R
Studies on corticotropin releasing factor: ion exchange chromotography of pituitary preparations.
Texas reports on biology and medicine 1960;18():133-46.
1959: GUILLEMIN R; SCHALLY A V
Re-evaluation of a technique of pituitary incubation in vitro as an assay for corticotropin releasing factor.
Endocrinology 1959;65():555-62.
1959: GUILLEMIN R
Hypothalamic control of the anterior hypophysis and its metabolic implications.
Diabetes 1959;8():352-7.
1959: STEELMAN S L; GUILLEMIN R
Adrenocorticotropic activty of alpha melanocyte stimulating hormone (alpha-MSH).
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;101():600-1.
1959: GUILLEMIN R; DEAR W E; LIEBELT R A
Nychthemeral variations in plasma free corticosteroid levels of the rat.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;101(2):394-5.
1959: NICHOLS B; GUILLEMIN R
Endogenous and exogenous vasopressin on ACTH release.
Endocrinology 1959;64(6):914-20.
1959: GUILLEMIN R; DEAR W E; NICHOLS B; LIPSCOMB H S
ACTH releasing activity in vivo of a CRF preparation and lysine vasopressin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;101(1):107-11.
1959: GUILLEMIN R; CLAYTON G W; LIPSCOMB H S; SMITH J D
Fluorometric measurement of rat plasma and adrenal corticosterone concentration; a note on technical details.
The Journal of laboratory and clinical medicine 1959;53(5):830-2.
1959: GUILLEMIN R; FORTIER C; LIPSCOMB H S
Comparison of in vitro and in vivo assaying procedures for rat adenohypophysial corticotropin.
Endocrinology 1959;64(2):310-2.
1959: SCHALLY A V; GUILLEMIN R
Concentration of corticotropin releasing factor by chromatography on carboxymethylcellulose.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1959;100(1):138-9.
1959: SCHALLY A V; LIPSCOMB H S; GUILLEMIN R
Chromatographic separation of oxytocin and vasopressin on carboxymethylcellulose.
Biochimica et biophysica acta 1959;31(1):252-4.
1958: GUILLEMIN R; NICHOLS B; LIPSCOMB H
[Hypothalamic factor in the secretion of ACTH; in vivo activity in animals with hypothalamic lesions or pharmacological block.]
Comptes rendus hebdomadaires des séances de l'Académie des sciences 1958;247(19):1662-4.
1958: HOFF H E; GUILLEMIN R; GEDDES L A
An 18th century scientist's observation of his own aphasia.
Bulletin of the history of medicine 1958;32(5):446-50.
1958: GUILLEMIN R; CLAYTON G W; SMITH J D; LIPSCOMB H S
Measurement of free corticosteroids in rat plasma: physiological validation of a method.
Endocrinology 1958;63(3):349-58.
1957: CLAYTON G W; BELL W R; GUILLEMIN R
Stimulation of ACTH-release in humans by non-pressor fraction from commercial extracts of posterior pituitary.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1957;96(3):777-9.
1957: WARD D N; GUILLEMIN R
A simple method for preparation of highly purified vasopressin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1957;96(3):568-70.
1957: HOFF H E; GEDDES L A; GUILLEMIN R
The anemograph of Ons-en-Bray: an early self-registering predecessor of the kymograph with translations of original description and a biography of the inventor.
Journal of the history of medicine and allied sciences 1957;12(4):424-48.
1957: GUILLEMIN R
[Hypothalamic control of ACTH secretion as observed in results of in vitro research.]
Endokrinologie 1957;34(4):193-201.
1957: GUILLEMIN R; HEARN W R; CHEEK W R; HOUSEHOLDER D E
Control of corticotrophin release: further studies with in vitro methods.
Endocrinology 1957;60(4):488-506.
1955: GUILLEMIN R; ROSENBERG B
Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures.
Endocrinology 1955;57(5):599-607.
1955: GUILLEMIN R; HEARN W R
ACTH release by in vitro pituitary; effect of pitressin and purified arginine-vasopressin.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.) 1955;89(3):365-7.
1955: GUILLEMIN R
A re-evaluation of acetylcholine, adrenaline, nor-adrenaline and histamine as possible mediators of the pituitary adreno-corticotrophic activation by stress.
Endocrinology 1955;56(3):248-55.
1954: MITCHELL M L; GUILLEMIN R; SALYE H
The effect of somatotrophic hormone on the growth of normal and hypophysectomized guinea pigs.
Endocrinology 1954;54(1):111-4.
1953: GUILLEMIN R; CONTI C
[Hypertension and hyalinosis due to methyl-androstenediol.]
Folia endocrinologica; mensile di incretologia e incretoterapia 1953;6(2):183-8.
1953: GUILLEMIN R; FORTIER C
Role of histamine in the hypothalamo-hypophyseal response to stress.
Transactions of the New York Academy of Sciences 1953;15(5):138-40.
1953: GUILLEMIN R
[Hypertension after administration of adrenal cortex hormones and adaptation diseases.]
Revue canadienne de biologie / éditée par l'Université de Montréal 1953;11(5):501-2.
1953: GUILLEMIN R
[Not Available]
Revue canadienne de biologie / éditée par l'Université de Montréal 1953;11(5):500-1.
1953: HORAVA A; GUILLEMIN R; SELYE H
[Effect of Reichstein's compound L on certain effects from the administration of an anterior pituitary lobe extract.]
Annales d'endocrinologie 1953;14(5):779-83.
1953: FORTIER C; GUILLEMIN R
[Study of the histaminergic mechanism of the stimulation of the pituitary-adrenal axis by stress.]
Annales d'endocrinologie 1953;14(1):42-5.
1953: GUILLEMIN R; FORTIER C
[Adaptation to the adrenocorticotropic effect of a synthetic antihistaminic (R.P. 3277).]
Annales d'endocrinologie 1953;14(1):38-41.
1952: GUILLEMIN R
Alarm reaction and the general adaptation syndrome.
Annals of western medicine and surgery 1952;6(6):347-9.
1952: DUCOMMUN P; GUILLEMIN R
[Hormonal pathogenesis of experimental cardiovascular lesions; cardiovascular lesions of adaptation diseases.]
Médecine et hygiène 1952;10(219):211.
1952: SELYE H; GUILLEMIN R
[General adaptation syndrome.]
Maroc médical 1952;31(323):259-63.
1952: GUILLEMIN R; SELYE H
[Nephrosclerotic and prophlogistic effect of various preparations of somatotropic hormones.]
Annales d'endocrinologie 1952;13(5):836-40.
1951: GUILLEMIN R
[Inhibiting action of phenergan (3277 R. P.) on the experimental hypertension syndrome produced by desoxycorticosterone acetate.]
La semaine des hôpitaux : organe fondé par l'Association d'enseignement médical des hôpitaux de Paris 1951;27(61-62):2518-24.
1951: GUILLEMIN R
[Parahydroxypropiophenone (H 365); a synthetic pituitary inhibitor?]
La Presse médicale 1951;59(39):799.
1951: GUILLEMIN R; FORTIER C
Inhibition of DCA induced hypertension and hyalinosis by a drug acting on membrane permeability.
Endocrinology 1951;48(5):617-22.
1950: GUILLEMIN R; SELYE H
[Action of mineral-corticoids on the behavior of the kidney towards vasopresor substances of angiotonin type.]
Revue canadienne de biologie / éditée par l'Université de Montréal 1950;9(3):309.
1950: GUILLEMIN R; SELYE H
[Mineral-corticoid inhibition of renal inactivation of vasopressive substances.]
Annales d'endocrinologie 1950;11(3):270-5.

Sign-in to see more